A new study from the Scripps Translational Science Institute, published in the American Journal of Medicine, shows that iRhythm's Zio patch, a wireless adhesive heart monitor patch, detects more ...
New research indicates a wireless device could do a better job than the Holter monitor, the standard of care for mobile heart rhythm monitoring over the past half-century. The Scripps Translational ...
Findings published in the American Heart Journal show higher clinical diagnostic yield and lower odds of retesting with Zio long-term continuous monitoring service (LTCM) compared to other LTCM and ...
New data from iRhythm Technologies has demonstrated that extending the cardiac monitoring duration for arrhythmia recurrence to 14 days resulted in a more complete clinical assessment in post-ablation ...
In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, ...
SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC) today announced results from two real-world retrospective analyses in post-ablation and pregnancy patient ...
Austin, TX, USA, June 19, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled "ECG Patch and Holter Monitor Market Size, Trends and Insights By Product Type ...
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) system, ...
SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) today announced that the results from the Cardiac Ambulatory Monitor EvaLuation of Outcomes and Time to Events (CAMELOT) study have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results